September 27, 2021
Impact investing is one of the major forces driving healthcare technology innovation, which has a plethora of new solutions entering the market regularly. The Covid-19 pandemic brought to light many of the issues in the healthcare sector. Technology is now working to fill many of those gaps.
- For example, Zipline used fleets of drones to distribute vaccines to out of reach populations around the globe after securing $250 million in funding.
- Healthcare is the third-largest portion of impact investing, lagging only climate change and financial services, but it’s the fastest-growing area.
- Venture capital in healthcare doubled in 2020 from 2019, and many see this capital as augmenting government and charitable giving to healthcare to improve access and distribution.
Breakthroughs in the sector include companies like HanGenix, which uses ultrasound technology to ensure safety procedures are followed by medical workers, and Plethy which syncs sensors and apps to improve post-orthopedic care.
FINSUM + Magnifi: Healthcare technology will likely continue to capture the attention of impact investors for the foreseeable future in the wake of the pandemic.
Why have 750+ Financial Advisors signed up for Magnifi?
Magnifi enables advisors to easily discover high-impact portfolio optimizations to win new clients and deepen existing relationships. With Magnifi, you can supercharge investment management workflows with artificial intelligence and natural-language search capabilities. Quickly optimize portfolios across fees, risk, return, and other key factors.
Learn more or schedule a demo now.
This blog is sponsored by Magnifi for Advisors. The information and data are as of the publish date unless otherwise noted and subject to change. This material is provided for informational purposes only and should not be construed as individualized investment advice or an offer or solicitation to buy or sell securities tailored to your needs. This information covers investment and market activity, industry or sector trends, or other broad-based economic or market conditions and should not be construed as investment research or advice. Investors are urged to consult with their financial advisors before buying or selling any securities. Although certain information has been obtained from sources believed to be reliable, we do not guarantee its accuracy, completeness or fairness. Past performance is no guarantee of future results. This content may not be reproduced or distributed to any person in whole or in part without the prior written consent of Magnifi. [As a technology company, Magnifi provides access to tools and will be compensated for providing such access. Magnifi does not provide brokerage or custody services.]